A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy - Alkhalaf, A; Klooster, A; van Oeveren, W (Diabetes Care, 2010)
doi:10.2337/dc09-2241